![Eurand Announces FDA Approval of EUR-1048 (Lamictal ODT), Co-Developed With GlaxoSmithKline | Fierce Biotech Eurand Announces FDA Approval of EUR-1048 (Lamictal ODT), Co-Developed With GlaxoSmithKline | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/Techonoly_watchara_tongnoi_GettyImages-1319893380_0.jpg?VersionId=3qAnUUISJ3Yyh7dVE95r0WziV0Ql7j0h)
Eurand Announces FDA Approval of EUR-1048 (Lamictal ODT), Co-Developed With GlaxoSmithKline | Fierce Biotech
Srinivas S Rao - Global Head, Translational In Vivo Models Global Research Platform - Sanofi | LinkedIn
![PDF) Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014 PDF) Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014](https://i1.rgstatic.net/publication/327654806_Trends_in_healthcare_utilization_and_costs_associated_with_pneumonia_in_the_United_States_during_2008-2014/links/5b9bf221299bf13e603169c4/largepreview.png)
PDF) Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014
Vincent Tong - Director, Head of Nonclinical Development and DMPK - Chinook Therapeutics, Inc. | LinkedIn
![Endpoints News — Sanofi offloads siRNA platform to low-profile biotech; WHO declares monkeypox a global health emergency Endpoints News — Sanofi offloads siRNA platform to low-profile biotech; WHO declares monkeypox a global health emergency](https://reports.endpts.com/assets/early_edition_header.jpg)